INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 17, 2007 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 628
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 500,000 | -- | 563,094 |
| May 12, 2016 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 230,684 | $20.32 | 563,564 |
| Mar 09, 2020 |
Director, President and Chief Scientific
Trans History: 628
|
Director, President and Chief Scientific | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 50,545 | $476.42 | 563,990 |
| Mar 10, 2020 |
Director, President and Chief Scientific
Trans History: 628
|
Director, President and Chief Scientific | Form 4 | Open market or private sale of non-derivative or derivative security | 5,258 | $471.34 | 564,988 |
| Nov 14, 2014 |
Director, President Regeneron Laboratori
Trans History: 628
|
Director, President Regeneron Laboratori | Form 4 | Bona fide gift | 2,313 | -- | 566,324 |
| Dec 18, 2015 |
Director, President Regeneron Laboratori
Trans History: 628
|
Director, President Regeneron Laboratori | Form 4 | Other acquisition or disposition | -- | -- | 567,976 |
| Nov 16, 2015 |
Director, President Regeneron Laboratori
Trans History: 628
|
Director, President Regeneron Laboratori | Form 4 | Bona fide gift | 1,612 | -- | 567,976 |
| Feb 13, 2014 |
Director, President Regeneron Laboratori
Trans History: 628
|
Director, President Regeneron Laboratori | Form 4 | Bona fide gift | 568,343 | -- | 568,343 |
| Aug 28, 2014 |
Director, President Regeneron Laboratori
Trans History: 628
|
Director, President Regeneron Laboratori | Form 4 | Bona fide gift | 294 | -- | 568,637 |
| May 12, 2020 |
Director, President & CEO
Trans History: 404
|
Director, President & CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 18,021 | $568.58 | 569,240 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.